Pneumonia outbreak in the city of Wuhan, China, prompted the finding of a novel strain of
severe acute respiratory syndrome virus (SARS-CoV-2). Here, we discuss potential long …

Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the
coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease …

Although increasing evidence confirms neuropsychiatric manifestations associated mainly
with severe COVID-19 infection, long-term neuropsychiatric dysfunction (recently …

Introduction Neurological complications among hospitalized COVID‐19 patients may be
associated with elevated neurodegenerative biomarkers. Methods Among hospitalized …

Since its first emergence in December 2019, coronavirus disease 2019 (COVID-19), caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has evolved into a …

Neuropsychiatric complications associated with coronavirus disease 2019 caused by the
Coronavirus SARS-CoV-2 (COVID-19) are increasingly appreciated. While most studies …

Patients with COVID-19 can have a variety of neurological symptoms, but the active
involvement of central nervous system (CNS) in COVID-19 remains unclear. While routine …

COVID-19 is a highly infectious viral disease caused by the novel coronavirus SARS-CoV-2.
While it was initially regarded as a strictly respiratory illness, the impact of COVID-19 on …

Background Fatigue and cognitive complaints are the most frequent persistent symptoms in
patients after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This …

COVID-19 is known to cause multi-organ dysfunction1-3 in acute infection, with prolonged
symptoms experienced by some patients, termed Post-Acute Sequelae of SARS-CoV-2 …